Neuronetics, Inc.
STIMNasdaq
$1.62
↓ -9.0%Jul 17 close · end-of-day
Price
1Y↓ -55.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$112.7M
Enterprise Value
$160.8M
P/E
—
P/S
0.7
P/B
8.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$151.6M
Net Income (TTM)
-$37.1M
Free Cash Flow (TTM)
—
Gross Margin
48.0%
Operating Margin
-19.4%
Net Margin
-24.5%
ROE
-279.8%
ROIC
-37.9%
Debt / Equity
4.6
Net Cash
-$48.1M
Return 1Y
-57.7%
Company profile
Neuronetics, Inc. offers non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
- CEO
- Keith J. Sullivan
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 180
- Headquarters
- Pennsylvania
- Website
- neurostar.com
Earnings
STIM Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$34.5M↑ +7.8%
Diluted EPS-$0.16↓ -23.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $49.2M | $55.3M | $65.2M | $71.3M | $74.9M | $149.2M |
| Gross profit | $37.7M | $43.7M | $49.7M | $51.7M | $54.2M | $72.3M |
| Operating income | -$22.3M | -$27.6M | -$35.1M | -$30.6M | -$34.6M | -$31.4M |
| Net income | -$27.5M | -$31.2M | -$37.2M | -$30.2M | -$43.7M | -$39.0M |
| Diluted EPS | -$1.46 | -$1.22 | -$1.38 | -$1.05 | -$1.38 | -$0.59 |
| Operating cash flow | -$28.4M | -$28.0M | -$30.7M | -$32.0M | -$31.0M | -$20.4M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 76.5% | 78.9% | 76.3% | 72.5% | 72.3% | 48.5% |
| Operating margin | -45.3% | -49.8% | -53.8% | -42.8% | -46.2% | -21.1% |
| Net margin | -55.7% | -56.4% | -57.0% | -42.3% | -58.4% | -26.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.4M | $18.5M | $22.5M | $32.0M | $38.1M | $37.3M | $41.8M | $34.5M |
| Gross profit | $12.2M | $14.0M | $14.9M | $15.7M | $17.8M | $17.1M | $21.7M | $16.2M |
| Operating income | -$8.5M | -$7.7M | -$11.5M | -$11.0M | -$8.1M | -$7.3M | -$5.0M | -$9.0M |
| Net income | -$9.8M | -$13.3M | -$12.7M | -$12.7M | -$10.1M | -$9.0M | -$7.2M | -$10.8M |
| Diluted EPS | -$0.33 | -$0.44 | -$0.34 | -$0.21 | -$0.15 | -$0.13 | -$0.10 | -$0.16 |
| Operating cash flow | -$5.0M | -$5.4M | -$8.6M | -$17.0M | -$3.5M | -$785,000.00 | $882,000.00 | -$9.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 74.0% | 75.6% | 66.2% | 49.2% | 46.6% | 45.9% | 52.0% | 46.9% |
| Operating margin | -51.7% | -41.7% | -51.0% | -34.4% | -21.1% | -19.6% | -12.1% | -26.1% |
| Net margin | -59.8% | -72.0% | -56.3% | -39.6% | -26.6% | -24.3% | -17.1% | -31.3% |
Company news
Jul 14, 2026
Jun 2, 2026
Jun 1, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.